Prostaglandin Analogues
Links shared publicly online about this topic
Prostaglandin analogue showing promise in clinical practice
osnsupersite.com — “Projected clinical outcomes for the 0.01% formulation of bimatoprost appear to be on the mark, according to a clinician. “We took an old” View full resource at osnsupersite.com
Most Recently Shared on January 24, 2012 at 7:30 pm By:
excellent results.
Education & Training
After graduating with top honors from the University of Southern California (USC), he received the prestigious Phi Beta Kappa Scholarship to attend Harvard Medical School. While in medical school, he accepted a research fellowship at the National Institutes of Health to study visual cognition. Dr. Richardson then completed an internal medicine internship at Huntington Memorial Hospital in Pasadena, which was followed by ophthalmology training at LAC+USC/Doheny Eye Institute in Los Angeles – one of the top ophthalmology residencies in the country.
Experience & Specialization
Dr. Richardson joined the San Gabriel Valley Eye Associates in 1999 and became San Gabriel’s first ophthalmologist to use such modern technologies as the accommodating Crystalens (with cataract surgery) and the iTrack microcatheter (canaloplasty glaucoma surgery). Dr. Richardson is among an elite group of glaucoma specialists in the country performing the highly specialized canaloplasty procedure. Patients have traveled from as far away as Mumbai, India to have canaloplasty by Dr. Richardson.
Dr. Richardson not only performs canaloplasty, he also teaches other surgeons how to do so. As one of the leading canaloplasty surgeons he regularly gives talks at the national meetings of eye surgeons. As part of his quest to make this safer glaucoma surgery available to glaucoma patients throughout the world, he is often asked to fly out to teach individual doctors how best to incorporate canaloplasty into their practices. Dr. Richardson was recently included among a panel of respected glaucoma surgeons whose goal was to find ways to make it easier for other eye surgeons to learn how to perform canaloplasty. You can read what this panel had to say here.
To learn more about Dr. David D. Richardson, visit http://david-richardson-md.com." /> David Richardson, MD - Glaucoma and Canaloplasty Surgeon Physician, Active Health Library, Doctor, and Ophthalmologist
Prostaglandin analogue showing promise in clinical practice http://t.co/P9bbWA2C #glaucoma
Xalatan(R) Receives Paediatric Indication In Europe
medicalnewstoday.com — “Pfizer announced that Xalatan 0.005% (latanoprost) has been approved by the European Commission for reduction of elevated intraocular pressure (IOP) in the treatment of paediatric patients with el” View full resource at medicalnewstoday.com
Most Recently Shared on October 22, 2010 at 12:37 pm By:
Xalatan(R) Receives Paediatric Indication In Europe Pfizer announced that Xalatan 0.005% (latanoprost) has been approve.. http://dld.bz/2EMY
Merck News Item
merck.com — “Merck News Item” View full resource at merck.com
Most Recently Shared on September 3, 2009 at 1:40 pm By:
eyeonfda Pharma and Health Lawyer
Merck Launches SAFLUTAN® (tafluprost) in International Markets - http://bit.ly/fUbwR
Ob/Gyn Article | Postpartum Hemorrhage
mdlinx.com — “Prostaglandin E2 Analogue Sulprostone for Treatment of Atonic Postpartum Hemorrhage” View full resource at mdlinx.com
Most Recently Shared on August 2, 2011 at 8:04 am By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Prostaglandin E2 Analogue Sulprostone for Treatment of Atonic Postpartum Hemorrhage: Obstetrics and Gynecology http://bit.ly/qvs4Zd #OBGYN
Sulprostone Underused for Atonic Postpartum Hemorrhage - QualityPoint Technologies
qualitypointtech.net — “The prostaglandin E2 analogue sulprostone is underused in women with severe atonic hemorrhage after vaginal delivery, French researchers maintain. Reuters Health Information” View full resource at qualitypointtech.net
Most Recently Shared on August 16, 2011 at 2:45 am By:
Sulprostone Underused for Atonic Postpartum Hemorrhage: The prostaglandin E2 analogue sulprostone is underused in ... http://t.co/vztk2gy
Study: Company sponsorship of glaucoma drug trials did not affect IOP measurements at 1 month
osnsupersite.com — “BOSTON — IOP measurements in randomized controlled trials investigating prostaglandin analogues do not appear to be affected by sponsorship of th” View full resource at osnsupersite.com
Most Recently Shared on July 10, 2009 at 3:22 pm By:
Study: Company sponsorship of #glaucoma drug trials did not affect IOP measurements at 1 month http://ow.ly/gYk1
Ob/Gyn Article | Postpartum Hemorrhage
mdlinx.com — “Prostaglandin E2 Analogue Sulprostone for Treatment of Atonic Postpartum Hemorrhage” View full resource at mdlinx.com
Most Recently Shared on August 3, 2011 at 5:21 pm By:
Roger D. Jones, PhD PhD, Doctor, Health Executive, and Health Social Media
Ob/Gyn Article | Postpartum Hemorrhage http://bit.ly/nDDs9I #Health #Medicine
FDA accepts Merck's SAFLUTAN NDA for standard review
news-medical.net — “Merck, known as MSD outside the United States and Canada, announced today that the New Drug Application for SAFLUTAN, Merck's investigational preservative-free prostaglandin analogue ophthalmic solution, has been accepted for standard review by the U.S. Food and Drug Administration.” View full resource at news-medical.net
Most Recently Shared on March 10, 2011 at 5:06 am By:
FDA accepts Merck's SAFLUTAN NDA for standard review: Merck, known as MSD outside the United States and Canada, ... http://bit.ly/g9Ozy6
Eyelash Growth Stimulators- Truth In Aging
truthinaging.com — “Truth in Aging delivers the honest truth about the beauty industry, informing readers about what cosmetics really work and why.” View full resource at truthinaging.com
Most Recently Shared on January 13, 2010 at 8:10 pm By:
Eyelash growth products- do they work and are they safe? The 2010 update. #eyelash http://ow.ly/W8Fg
IOP-lowering treatment has promising results in phase 2b study
osnsupersite.com — “SOPHIA ANTIPOLIS, France — A randomized phase 2b study of various doses of a novel nitric oxide-donating prostaglandin F2 alpha analogue demonstrated” View full resource at osnsupersite.com
Most Recently Shared on March 14, 2012 at 3:55 pm By:
Glaucoma treatment: http://t.co/DhE45N2v - IOP-lowering treatment has promising results in phase 2b study
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Featuring the top 3 experts for this topic
-
excellent results.
Education & Training
After graduating with top honors from the University of Southern California (USC), he received the prestigious Phi Beta Kappa Scholarship to attend Harvard Medical School. While in medical school, he accepted a research fellowship at the National Institutes of Health to study visual cognition. Dr. Richardson then completed an internal medicine internship at Huntington Memorial Hospital in Pasadena, which was followed by ophthalmology training at LAC+USC/Doheny Eye Institute in Los Angeles – one of the top ophthalmology residencies in the country.
Experience & Specialization
Dr. Richardson joined the San Gabriel Valley Eye Associates in 1999 and became San Gabriel’s first ophthalmologist to use such modern technologies as the accommodating Crystalens (with cataract surgery) and the iTrack microcatheter (canaloplasty glaucoma surgery). Dr. Richardson is among an elite group of glaucoma specialists in the country performing the highly specialized canaloplasty procedure. Patients have traveled from as far away as Mumbai, India to have canaloplasty by Dr. Richardson.
Dr. Richardson not only performs canaloplasty, he also teaches other surgeons how to do so. As one of the leading canaloplasty surgeons he regularly gives talks at the national meetings of eye surgeons. As part of his quest to make this safer glaucoma surgery available to glaucoma patients throughout the world, he is often asked to fly out to teach individual doctors how best to incorporate canaloplasty into their practices. Dr. Richardson was recently included among a panel of respected glaucoma surgeons whose goal was to find ways to make it easier for other eye surgeons to learn how to perform canaloplasty. You can read what this panel had to say here.
To learn more about Dr. David D. Richardson, visit http://david-richardson-md.com." />David Richardson, MD - Glaucoma and Canaloplasty Surgeon
Eye Surgeon | Los Angeles | Glaucoma and Canaloplasty Surgeon
Dr. David Richardson is a Southern California board certified eye surgeon specializing in the treatment of Cataract and Glaucoma. He is also the medical director of San Gabriel Valley Eye Associates, located in Pasadena, California. Dr. Richardson has performed thousands of advanced cataract and Canaloplasty procedures with excellent results.
Education & Training
After graduating with top honors from the University of Southern California (USC), he received the prestigious Phi Beta Kappa Scholarship to attend Harvard Medical School. While in medical school, he accepted a research fellowship at the National Institutes of Health to study visual cognition. Dr. Richardson then completed an internal medicine internship at Huntington Memorial Hospital in Pasadena, which was followed by ophthalmology training at LAC+USC/Doheny Eye Institute in Los Angeles – one of the top ophthalmology residencies in the country.
Experience & Specialization
Dr. Richardson joined the San Gabriel Valley Eye Associates in 1999 and became San Gabriel’s first ophthalmologist to use such modern technologies as the accommodating Crystalens (with cataract surgery) and the iTrack microcatheter (canaloplasty glaucoma surgery). Dr. Richardson is among an elite group of glaucoma specialists in the country performing the highly specialized canaloplasty procedure. Patients have traveled from as far away as Mumbai, India to have canaloplasty by Dr. Richardson.
Dr. Richardson not only performs canaloplasty, he also teaches other surgeons how to do so. As one of the leading canaloplasty surgeons he regularly gives talks at the national meetings of eye surgeons. As part of his quest to make this safer glaucoma surgery available to glaucoma patients throughout the world, he is often asked to fly out to teach individual doctors how best to incorporate canaloplasty into their practices. Dr. Richardson was recently included among a panel of respected glaucoma surgeons whose goal was to find ways to make it easier for other eye surgeons to learn how to perform canaloplasty. You can read what this panel had to say here.
To learn more about Dr. David D. Richardson, visit http://david-richardson-md.com. -
medical_tweets
-
eyeonfda
Author of the blog Eye on FDA - www.eyeonfda.com
Advertisement
